- Home
- UAMY vs BWAY Comparison
UAMY vs BWAY Comparison
Compare UAMY & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- BWAY
- Stock Information
- Founded
- UAMY 1968
- BWAY 2003
- Country
- UAMY United States
- BWAY Israel
- Employees
- UAMY N/A
- BWAY N/A
- Industry
- UAMY Metal Fabrications
- BWAY Medical/Dental Instruments
- Sector
- UAMY Industrials
- BWAY Health Care
- Exchange
- UAMY Nasdaq
- BWAY Nasdaq
- Market Cap
- UAMY 316.8M
- BWAY 280.7M
- IPO Year
- UAMY N/A
- BWAY 2019
- Fundamental
- Price
- UAMY $4.51
- BWAY $15.85
- Analyst Decision
- UAMY Strong Buy
- BWAY Strong Buy
- Analyst Count
- UAMY 5
- BWAY 2
- Target Price
- UAMY $3.60
- BWAY $18.00
- AVG Volume (30 Days)
- UAMY 6.3M
- BWAY 94.6K
- Earning Date
- UAMY 08-12-2025
- BWAY 08-13-2025
- Dividend Yield
- UAMY N/A
- BWAY N/A
- EPS Growth
- UAMY N/A
- BWAY 515.14
- EPS
- UAMY N/A
- BWAY 0.11
- Revenue
- UAMY $25,728,046.00
- BWAY $46,084,000.00
- Revenue This Year
- UAMY $209.07
- BWAY $339.49
- Revenue Next Year
- UAMY $98.95
- BWAY $21.74
- P/E Ratio
- UAMY N/A
- BWAY $55.17
- Revenue Growth
- UAMY 134.91
- BWAY 26.50
- 52 Week Low
- UAMY $0.49
- BWAY $7.06
- 52 Week High
- UAMY $5.13
- BWAY $16.06
- Technical
- Relative Strength Index (RSI)
- UAMY 59.32
- BWAY 70.56
- Support Level
- UAMY $4.25
- BWAY $15.25
- Resistance Level
- UAMY $4.69
- BWAY $16.06
- Average True Range (ATR)
- UAMY 0.38
- BWAY 0.68
- MACD
- UAMY -0.05
- BWAY 0.06
- Stochastic Oscillator
- UAMY 48.33
- BWAY 91.80
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.